Cencora Inc. (COR)

NYSE: COR · USD

$311

+1.27 (+0.4%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-28 02:00 UTC. Latest published research analyzed 2026-05-13 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh COR analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: COR rated Strong Buy

COR is rated Strong Buy at $260.93 versus the reconciled fair value midpoint of $427.57, implying +63.86% upside/downside. Confidence is separately disclosed at 78/100.

Fair value (mid)

$428 / share

$342 – $515

Upside to FV

+63.9%

from $311

Confidence

78/100

Moat

9/10

Read full analysis

Market cap	$50.8B
Revenue (ttm)	328.7B
Net income (ttm)	2.5B
EPS (ttm)	$13.1
Shares out	194.6M
P/E (trailing)	23.8x
P/E (forward)	13.2x
Dividend	$2.40 (0.77%)
Volume	1,004,598
Beta	0.58
Price target	$356	+14.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 328.7B
Net income (ttm): 2.5B
EPS (ttm): $13.1
P/E (trailing): 23.8x
P/E (forward): 13.2x
Market cap: $50.8B

Item	P1	P2	P3	P4	Trend
Period	2022-09-30	2023-09-30	2024-09-30	2025-09-30	Trend
Revenue	$238.59B	$262.17B	$293.96B	$321.33B	+10.4%
Gross profit	$8.30B	$8.96B	$9.91B	$11.48B	+11.4%
Operating income	$2.75B	$2.69B	$3.16B	$3.93B	+12.6%
Net income	$1.70B	$1.75B	$1.51B	$1.55B	-2.9%
EPS (diluted)	$8.04	$8.53	$7.53	$7.96	-0.3%
EBITDA	$3.10B	$3.37B	$3.37B	$3.75B	+6.5%
R&D	—	—	—	—	—
SG&A	$4.85B	$5.31B	$5.66B	$6.49B	+10.2%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All COR indicators

Market & fundamental data

Available fields

286

Groups with data

Currency

USD

Showing 286 of 286 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001140859
Company name	Cencora, Inc.
Country	United States
Country code	US
Cusip	03073E105
Employees	51,000
Employees Change	5,000%
Employees Change Percent	10.87
Enterprise value	$73.5B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Distribution
Industry PE	27.7
Industry PE Fwd	18.22
Isin	US03073E1055
Last refreshed	2026-07-28
Market cap	$60.5B
Market cap category	Large-Cap
Price	$311
Price currency	USD
Rev Per Employee	6,444,706.24x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	5122
Symbol	COR
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.21%
EV Earnings	28.82x
EV Sales Forward	0.21x
EV/EBIT	26.33x
EV/EBITDA	19.13x
EV/FCF	47.14x
EV/Sales	0.22x
FCF yield	2.57%
Forward P/E	16.71x
P/B ratio	17.82x
P/E ratio	23.84x
P/S ratio	0.18x
PE Ratio10 Y	21.84x
PE Ratio3 Y	28.46x
PE Ratio5 Y	24.5x
PEG ratio	1.65x
PS Forward	0.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.85%
EBITDA Margin	1.17%
FCF margin	0.47%
Gross margin	3.8%
Gross Profit	$12.5B
Gross Profit Growth	22.5%
Gross Profit Growth Q	24.84%
Gross Profit Growth3 Y	14.13%
Gross Profit Growth5 Y	17.55%
Net Income	$2.5B
Net Income Growth	50.51%
Net Income Growth Q	128.64%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	16.38%
Pretax Margin	1.07%
Profit Margin	0.78%
Profit Per Employee	$49,974
Profitable Quarters	$2
Profitable Years	5
ROA	3.49
Roa5y	2.99
ROCE	10.93
ROE	107.1
ROIC	23.2
Roic5y	47.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.36%
Cagr15y	16.29%
Cagr1y	7.98%
Cagr20y	15.92%
Cagr3y	19.36%
Cagr5y	22.09%
Div CAGR10	6.02%
Div CAGR3	7.06%
Div CAGR5	6.19%
EPS Growth	52.02
EPS Growth Q	128.3
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	18.86
FCF Growth	-56.42%
FCF Growth Q	-63.6%
FCF Growth3 Y	-13.97%
FCF Growth5 Y	3.95%
OCF Growth	-44.63%
OCF Growth Q	-60.06%
OCF Growth10 Y	-5.28%
OCF Growth3 Y	-7.89%
OCF Growth5 Y	6.51%
Revenue Growth	5.95x
Revenue Growth Q	3.85x
Revenue Growth Quarters	55x
Revenue Growth Years	13x
Revenue Growth3 Y	9.91x
Revenue Growth5 Y	10.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$4.3
Assets	$81.7B
Cash	$2.2B
Current Assets	$53.1B
Current Liabilities	$56.1B
Debt	$15.1B
Debt EBITDA	$3.93
Debt Equity	$4.21
Debt FCF	$9.69
Equity	$3.6B
Interest Coverage	5.88
Liabilities	$78.1B
Long Term Assets	$28.5B
Long Term Liabilities	$21.9B
Net Cash	$-12.9B
Net Cash By Market Cap	$-21.33
Net Debt EBITDA	$3.36
Net Debt Equity	$3.6
Net Debt FCF	$8.29
Tangible Book Value	$-19.1B
Tangible Book Value Per Share	$-98.22
WACC	6.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.95
Inventory Turnover	16.23
Net Working Capital	$-4.5B
Quick ratio	0.48
Working Capital	$-3B
Working Capital Turnover	$-67.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.91%
Dividend Growth	8.8%
Dividend Growth Years	21%
Dividend per share	$2.4
Dividend Years	26
Dividend Yield	0.77%
Ex Div Date	2026-05-15
Last Dividend	$0.6
Payout Frequency	Quarterly
Payout Ratio	18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	317.3%
1Y total return	7.97%
200-day SMA	324.5
3Y total return	70.09%
50-day SMA	284.2
50-day SMA vs 200-day SMA	50under200
5Y total return	171.21%
All Time High	377.5
All Time High Change	-17.58%
All Time High Date	2025-11-25
All Time Low	2.47
All Time Low Change	12,502.27%
All Time Low Date	1995-08-09
ATR	7.35
Beta	0.58
Beta1y	-0.14
Beta2y	0.05
Ch YTD	-7.88
High	313.9
High52	377.5
High52 Date	2025-11-25
High52ch	-17.58%
Low	308.1
Low52	244.8
Low52 Date	2026-05-06
Low52ch	27.09%
Ma50ch	9.5%
Premarket Change Percent	-0.29
Premarket Price	$309
Premarket Volume	191
Price vs 200-day SMA	-4.13%
RSI	63.81
RSI Monthly	55.25
RSI Weekly	51.26
Sharpe ratio	0.28x
Sortino ratio	0.51
Total Return	1.68%
Tr YTD	-7.51
Tr15y	861.62%
Tr1m	8.74%
Tr1w	2.36%
Tr3m	1.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	7
Analyst Price Target Top	$375
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$4.36
Earnings EPS Estimate Growth	9
Earnings Revenue Estimate	84,346,987,624x
Earnings Revenue Estimate Growth	4.57x
Operating Income	$4.3B
Operating Income Growth	34.13
Operating Income Growth Q	34.49
Operating Income Growth3 Y	19.3
Operating Income Growth5 Y	12.65
Operating margin	1.3
Price target	$356
Price Target Change	$14.36
Price Target Change Top	$20.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184,002,654%
Float Percent	94.57%
Net Borrowing	4,117,928,000
Shares Insiders	0.38%
Shares Institutions	96.97%
Shares Out	194,561,060
Shares Qo Q	0.03%
Shares Yo Y	-0.91%
Short Float	3.19%
Short Ratio	3.5
Short Shares	3.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.4B
Adjusted OCF	2,132,951,000
Average Volume	1,375,221.2x
Bv Per Share	17.46
CAPEX	$-718M
Ch10y	263
Ch15y	679.2
Ch1m	8.74
Ch1w	2.36
Ch1y	7.16
Ch20y	1,345.9
Ch3m	0.96
Ch3y	65.76
Ch5y	157.6
Ch6m	-12.48
Change	0.41%
Change From Open	0.74
Close	309.9
Days Gap	-0.34
Depreciation Amortization	1,038,053,000
Dollar Volume	312,580,667.7
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$2.8B
EBITDA	$3.8B
EPS	$13.05
F Score	5
FCF	$1.6B
FCF EV Yield	2.12x
FCF Per Share	$8.01
Financing CF	3,553,473,000
Fiscal Year End	September
Founded	2,001
Goodwill	16,452,669,000
Graham Number	71.61569
Graham Upside	-76.98
Income Tax	$954.1M
Investing CF	-5,730,847,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2009-06-16
Last Split Type	Forward
Last10k Filing Date	2025-11-25
Lynch Fair Value	$214
Lynch Upside	-31.28
Ma150	317.9
Ma150ch	-2.13%
Ma20	301.1
Ma20ch	3.33%
Net CF	57,696,000
Next Earnings Date	2026-08-05
Open	308.9
Optionable	Yes
P FCF Ratio	38.85
P FCF Ratio SBC	42.78
P OCF Ratio	26.6
P OCF Ratio SBC	28.38
Payment Date	2026-06-01
Position In Range	52.34
Ppne	2,805,419,000
Pre Close	309.9
Price Date	2026-07-27
Price EBITDA	$15.77
Relative Volume	0.73x
Revenue	328,680,018,000x
SBC By Revenue	0.04x
Share Based Comp	143,183,000
Tax By Revenue	0.29x
Tax Rate	27.21%
Tr20y	1,820.83%
Tr6m	-12.13%
Us State	Pennsylvania
Volume	1,004,598
Z Score	4.77

Frequently asked questions

About this COR report

What is the latest published COR stock rating?

Cencora Inc. is shown with strong buy in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COR analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/COR/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for COR?

The latest published report analyzed 2026-05-13 frames COR around USD 342 to USD 515. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the COR page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Cencora Inc. (COR)

Coverage state: Latest published research available

Generate a fresh COR analysis

Our latest published analysis: COR rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · COR

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All COR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on COR

Frequently asked questions